Brainstorm Cell Therapeutics Inc.

BCLI | OTC

Price Alert Chart Builder DCF Calculator

$0.82

$0.00 (-0.01%)

Nov 2, 2026, 1:16 PM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Profile

-0.01%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Feb 25, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $9.05M

1D Range

0.80 0.85

52W Range

0.46 1.92

Valuation (TTM)

PE -

PB N/A

EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target N/A

Cash Flow

FCF Yield N/A

SBC Adj. FCF Yield N/A

SBC Impact -21.8%

Margins

Gross Margin N/A

Operating Margin -1283.6%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | 66.4%

Dil EPS 3Y | 5Y 40.6% | 23.2%

FCF 3Y | 5Y 21.9% | 4.5%

Returns

ROA N/A

ROE N/A

ROIC N/A

Financial Health

Net Debt

$96K

Current Ratio N/A

Interest Coverage N/A

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The compa...

Sector Healthcare

Industry Biotechnology

Employees 27

IPO Date Oct 7, 2003

Website www.brainstorm-cell.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.